Literature DB >> 8335041

Perspectives of in vitro dissolution tests in establishing in vivo/in vitro correlations.

M Siewert1.   

Abstract

Perspectives of in vitro dissolution tests in establishing an in vivo/in vitro correlation are considered at three different levels. The first involves the selection of a drug product, or suitable batch(es), for the correlation study. This requires evaluation of the biopharmaceutical properties of the proposed drug from a profile compiled from a set of dissolution tests under different experimental conditions. These characteristics are needed for properly designing the in vivo study and are also referred to when only a poor correlation is obtained. The second is to define the specific in vitro test system either prospectively, by assessing plausibility of in vitro results, or retrospectively, after interpretation of in vivo data. This distinct test system has to be validated both physically and analytically. The third aspect of dissolution testing for correlations is to provide sound data and derived parameters in consideration of statistical aspects (variability) and of a sufficient number of suitable sampling intervals. In vitro models proposed for the special study of the simulation of food effects on bioavailability are discussed but concluded to be as yet not satisfactory for general application.

Mesh:

Year:  1993        PMID: 8335041     DOI: 10.1007/BF03220004

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  [The bioequivalence of two different batches of two nifedipine controlled-release preparations with deficient batch conformity in in vitro liberation studies].

Authors:  U Theiss; E Gebhardt; J Müller
Journal:  Arzneimittelforschung       Date:  1992-05

2.  Influence of higher rates of agitation on release patterns of immediate-release drug products.

Authors:  V P Shah; M Gurbarg; A Noory; S Dighe; J P Skelly
Journal:  J Pharm Sci       Date:  1992-06       Impact factor: 3.534

3.  In Vitro-in Vivo Correlation: An Unrealistic Problem.

Authors:  R Hüttenrauch; P Speiser
Journal:  Pharm Res       Date:  1985-05       Impact factor: 4.200

4.  Effects of sinker shapes on dissolution profiles.

Authors:  R A Soltero; J M Hoover; T F Jones; M Standish
Journal:  J Pharm Sci       Date:  1989-01       Impact factor: 3.534

5.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

6.  Dissolution kinetics of drugs in human gastric juice--the role of surface tension.

Authors:  P Finholt; S Solvang
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

7.  Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation.

Authors:  P K Maturu; V K Prasad; W N Worsley; G K Shiu; J P Skelly
Journal:  J Pharm Sci       Date:  1986-12       Impact factor: 3.534

8.  A novel approach to the specification of in-vitro dissolution boundaries based on regulatory requirements for bioequivalence.

Authors:  V W Steinijans; R Dietrich; H Trautmann; R Sauter; G Benedikt
Journal:  Arzneimittelforschung       Date:  1988-08

9.  Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.

Authors:  D C Cox; W B Furman; D P Page
Journal:  J Pharm Sci       Date:  1983-09       Impact factor: 3.534

10.  In vitro--in vivo correlation, a time scaling problem? Basic techniques for testing equivalence.

Authors:  D Brockmeier; D Voegele; H M von Hattingberg
Journal:  Arzneimittelforschung       Date:  1983
  10 in total
  4 in total

1.  Survey: calculation of the characteristics of oral diffusion-controlled release dosage forms related to the drug.

Authors:  I D Rosca; J M Vergnaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

2.  Calculation of the antibiotic level in the lung tissue and bronchial secretion with an oral controlled-release dosage form.

Authors:  M Saïdna; E M Ouriemchi; J M Vergnaud
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

3.  Assessment of blood level with controlled-release dosage forms: effect of the rate constant of elimination of the drug.

Authors:  A Aïnaoui; J M Vergnaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

4.  In vitro- in vivo correlation's dissolution limits setting.

Authors:  B Roudier; B M Davit; E Beyssac; J-M Cardot
Journal:  Pharm Res       Date:  2014-03-28       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.